Tuesday - February 3, 2026
Rutgers Health Begins Clinical Trial to Determine If B1 Can Slow Alzheimer's Disease
January 14, 2026
NEW BRUNSWICK, New Jersey, Jan. 14 (TNSjou) -- Rutgers University issued the following news:

* * *

Rutgers Health Begins Clinical Trial to Determine if B1 Can Slow Alzheimer's Disease

Researchers seek participants for a federally funded study to determine if benfotiamine, a synthetic version of thiamine (vitamin B1), can help slow disease progression

By Patti Zielinski

Researchers at Rutgers Robert Wood Johnson Medical School . . .

Targeted News Service Document Request Form

This document is available to you by e-mail if you complete the form below with relevant information. There may be a fee for this article or ongoing service of similar materials. We will be in touch shortly.

Name:
What's your
Affiliation		 Government Newspaper / Media Business
Public Policy Individual / Student Educators
Email:
Phone:
Organization, if any:
State/Country you are in:
Additonal questions
or comments:

Click here for more information about our products

Click here for more information about our products